Anti-Ascaris Immunoglobulin E Associated with Bronchial Hyper-reactivity in 9-year-old Rural Bangladeshi Children
Overview
Authors
Affiliations
Background: Studies have addressed the immunomodulatory effects of helminths and their protective effects upon asthma. However, anti-Ascaris IgE has been reported to be associated with an increased risk of asthma symptoms. We examined the association between serum levels of anti-Ascaris IgE and bronchial hyper-responsiveness (BHR) in children living in rural Bangladesh.
Methods: Serum anti-Ascaris IgE level was measured and the BHR test done in 158 children aged 9 years selected randomly from a general population of 1705 in the Matlab Health and Demographic Surveillance Area of the International Centre for Diarrhoeal Disease Research, Bangladesh. We investigated wheezing symptoms using a questionnaire from the International Study of Asthma and Allergies in Childhood. BHR tests were successfully done on 152 children (108 'current wheezers'; 44 'never-wheezers'). We examined the association between anti-Ascaris IgE level and wheezing and BHR using multiple logistic regression analyses.
Results: Of 108 current-wheezers, 59 were BHR-positive; of 44 never-wheezers, 32 were BHR-negative. Mean anti-Ascaris IgE levels were significantly higher (12.51 UA/ml; 95% confidence interval (CI), 9.21-17.00) in children with current wheezing with BHR-positive than in those of never-wheezers with BHR-negative (3.89; 2.65-5.70; t test, p < 0.001). A BHR-positive test was independently associated with anti-Ascaris IgE levels with an odds ratio (OR) = 7.30 [95% CI, 2.28-23.33], p = 0.001 when adjusted for total IgE, anti-Dermatophagoides pteronyssinus IgE, pneumonia history, parental asthma, Trichuris infection, forced expiratory volume in one second, eosinophilic leukocyte count, and sex.
Conclusions: Anti-Ascaris IgE level is associated with an increased risk of BHR among 9-year-old rural Bangladeshi children.
Human Ascaris infection is associated with higher frequencies of IL-10 producing B cells.
Zakzuk J, Lopez J, Akdis C, Caraballo L, Akdis M, Veen W PLoS Negl Trop Dis. 2024; 18(9):e0012520.
PMID: 39312581 PMC: 11537421. DOI: 10.1371/journal.pntd.0012520.
Microbes little helpers and suppliers for therapeutic asthma approaches.
Reuter S, Raspe J, Taube C Respir Res. 2024; 25(1):29.
PMID: 38218816 PMC: 10787474. DOI: 10.1186/s12931-023-02660-7.
Takeuchi H, Hasan S, Zaman K, Takanashi S, Hore S, Yeasmin S Respir Res. 2021; 22(1):35.
PMID: 33536028 PMC: 7856731. DOI: 10.1186/s12931-021-01629-8.
Takeuchi H, Khan M, Zaman K, Takanashi S, Hasan S, Yunus M J Immunol Res. 2019; 2019:4236825.
PMID: 31886302 PMC: 6915125. DOI: 10.1155/2019/4236825.
Takeuchi H, Khan M, Ahmad S, Hasan S, Alam M, Takanashi S Immun Inflamm Dis. 2019; 7(3):160-169.
PMID: 31256445 PMC: 6688081. DOI: 10.1002/iid3.253.